CureVac adds one more patent to the growing tally in its counterclaim against Pf...
Theseus Pharmaceuticals has terminated its pan-variant tyrosine kinase receptor ...
Vistagen has received a Canadian Notice of Allowance for patent that is related ...
Gilead Sciences has entered into collaborations with CHAI and Penta ID network t...
AstraZeneca and Merck have received conditional approval from Health Canada for ...
Emmaus Life Sciences has received marketing authorisation for Endari (L-glutamin...
The offering follows recent lucrative deals with Novartis and Bayer for the use ...
Popular GLP-1 drugs like Ozempic and Mounjaro lead patients to lose both fat and...
A key Biden administration official told Covid-19 vaccine manufacturers that the...
Three sales executives, all of them women, have filed suit against Grail, a canc...
A group of Democratic senators are pressing a national panel to make a move that...
Big Health's acquisition of Limbix comes at a time when many digital health comp...
The initiative comes with a $12.3 billion price tag — and over 10 years, the sav...
With momentum on Alzheimer’s therapies, Europe sees delivery challenges ahead, too.
In N.C., Mandy Cohen built bridges to the GOP. Can she find consensus as the new...
Over the past roughly 18 months, Moody’s ratings have been withdrawn on nearly $...
